Home/ Supplements/ Electrolytes/ Liposomal Magnesium ATP

Liposomal Magnesium ATP

product on market Tablet or Pill Cardiovascular Research Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Magnesium and calcium are essential minerals that support muscle function and bone health, with strong evidence supporting their physiological roles. Adenosine triphosphate (ATP) serves as a primary energy source for cellular processes. Research coverage for this specific combination is limited, though the individual components are generally well-tolerated.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Liposomal Magnesium ATP
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
70 mg (7% DV)
30 mg (8% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)

Other Ingredients

Cellulose Stearic Acid Lecithin Hydroxypropyl Methylcellulose Magnesium Stearate Silicon Dioxide Modified Cellulose Gum Food Glaze
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions Take one or two tablets daily, or as directed by a physician.

Formulation Notes

Magnesium ATP is a scientifically-designed supplement containing the essential mineral, magnesium, in a bio-available form.

This unique formula is adsorbed to multilameller liposomes for maximal absorption. The tablet is processed with an enteric coating to protect the delicate molecules from denaturation in the stomach.

Contains no yeast, corn, wheat, phenols, egg or milk.

Gluten free, casein free

Additional Information

Ecological Formulas

Metadata

Product Details

UPC / SKU6 96859 13088 5
DSLD Entry Date2023-03-22
Product TypeOther Combinations
FormTablet or Pill
DSLD ID283456
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.